Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Pre-IPOs
Unlock full access to global stock IPOs
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Pfizer Ends Early-Stage Cancer Trial, Trimming Its Oncology Pipeline
Pfizer Inc. (PFE) has terminated its Phase 1 trial for the experimental cancer drug PF-08046037, which aimed to evaluate its efficacy as a monotherapy and in combination with sasanlimab for advanced malignancies. The decision is viewed as pipeline pruning rather than a major setback, as the program was early-stage and high-risk, suggesting Pfizer may reallocate resources to higher-conviction oncology programs. This move impacts company sentiment regarding R&D discipline and oncology focus but is unlikely to affect near-term earnings.